Horsemint

Other Names

American HorsemintBee BalmBergamotBergamote SauvageBiblical MintBrookmintDotted BeebalmDotted HorsemintEastern HorsemintEnglish HorsemintFillymintHabakLong-leaved HorsemintLong-leaved MintMenta de CaballoMentha capensisMentha incanaMentha longifoliaMentha mollissimaMentha spicata var. longifoliaMentha sylvestrisMentha tomentosaMenthe à Longues FeuillesMenthe AnglaiseMenthe ArgentéeMenthe BlancheMenthe ChevalineMenthe de ChevalMenthe SauvageMenthe SylvestreMonarda LuteaMonarda punctataMonarde PonctuéeOswego TeaPudinaSpotted BeebalmSpotted HorsemintSpotted MonardaSt. John's HorsemintThé d'OswegoThé de PennsylvanieWild BergamotWild MintYellow Dotted Mint

Synopsis

Horsemint (Monarda punctata L.): A Comprehensive Reference

1. Identity and Botanical Classification

Nomenclature and Taxonomy

Monarda punctata L. is a herbaceous plant in the mint family, Lamiaceae, native to eastern Canada, the eastern United States, and northeastern Mexico. Common names include spotted beebalm and horsemint. Additional vernacular names include dotted horsemint, dotted monarda, and eastern horsemint. Linnaeus formally described the species in his Species Plantarum in 1753. Linnaeus chose the generic name Monarda to commemorate Nicholás Monardes (1493–1588), a Spanish doctor and botanist based in Seville; Monardes never visited the Americas, but described plants brought to Spain by others.

The specific epithet punctata is Latin for "spotted" and references the violet speckles that dot the corolla. Several infraspecific varieties are recognized, including var. punctata, var. arkansana, var. correllii, var. lasiodonta, var. occidentalis, and var. villicaulis, among others.

The genus Monarda L. is now reckoned to contain 22 species, all natives of North America, from Vermont to northern Mexico. The name "horsemint" is sometimes applied loosely to other Monarda species, including M. fistulosa (wild bergamot), but in the most precise usage it refers specifically to M. punctata. The title "bee balm" refers to bees' appreciation of a plant rather than the plant itself; for this reason, many different species are known commonly as "bee balm," including Monarda didyma and M. fistulosa. To distinguish this species from others, the common name "horsemint" or the scientific name Monarda punctata is used.

Botanical Description and Natural Habitat

It is a thyme-scented plant with heads of purple-spotted tubular yellow flowers above rosettes of large white- or pink-tipped bracts. Spotted beebalm is an herbaceous perennial in the mint family (Lamiaceae), native to the eastern United States from New Jersey to southern Florida and west to Texas. An aromatic erect perennial ranging from only 6 inches to almost 3 feet tall, it grows best in lean, dry, sandy soils with plenty of sun and air circulation. Its phenological window spans late July to September for flowering, with fruiting in September to October. Habitat includes maritime forests, dunes, roadsides, and rocky or sandy woodlands.

This is a fairly typical member of the mint family with square stems and opposite leaves. The leaves are aromatic when brushed. Monarda punctata belongs to the mint, or Labiatae (Lamiaceae) family, whose other members include thyme, basil, rosemary, and oregano.

Common Preparation and Dosage Forms

Horsemint has been prepared in several forms across both historical and modern contexts. The principal preparations documented in the historical and scientific literature are:

Infusion (tea): It makes a useful addition to diaphoretic drinks in the treatment of recent colds, catarrhal and typhus fevers, and measles; it is used by infusion.
Essential oil (Oleum Monardae): A volatile oil distilled from the fresh herb of Monarda punctata, L. (Labiatae). Oil of horsemint is obtained from the fresh herb by distillation with water, yielding about 3 percent. The oil is of a yellowish or brownish-amber color, having a penetrating, aromatic, thyme-like odor, and a strong, pungent, somewhat acrid taste; it is soluble in alcohol.
Poultice (external): It was applied externally as a poultice to treat swellings and rheumatic pains.
Powder (insufflation): This plant, along with other plants, was ground into a powder and snuffed up the nostrils to relieve a sick headache.
Edible/culinary: The leaves can be used as a substitute for thyme (Thymus spp.). Edible parts include the leaves—raw or cooked—used as a flavoring in salads and cooked foods, and also as an aromatic tea.

Regarding historical dosage of the oil, King's American Dispensatory (1898) stated a dose of the oil of 2 to 5 drops on sugar (as recorded in Henriette's Herbal, Oleum Monardae entry). No standardized clinical dosage forms for M. punctata itself have been established in modern regulatory or pharmacopeial literature. Scientific studies have used the essential oil as a test substance in laboratory settings rather than as a defined oral supplement dose.

2. Traditional and Historical Use

Indigenous North American Traditions

Thymol has antiseptic and anaesthetic properties, and the medicinal uses of horsemint were discovered by a number of North American tribes, including the Meskwaki, Delaware, Mohegan, and Nanticoke, who used it to treat colds, skin problems, fevers, and even headaches.

Specific ethnobotanical accounts documented by the USDA NRCS detail the following tribal uses:

Dotted horsemint was used by the Meskwaki to treat colds and catarrh in a mixture with the leaves of Ranunculus delphinifolius and the disk florets of Helenium autumnale.
This plant, along with other plants, was ground into a powder and snuffed up the nostrils to relieve a sick headache.
Taken with the roots of Asarum canadense, Euphorbia corollata, and Brauneria angustifolia, these plants relieved stomach cramps.
The Delaware washed patients' faces with an infusion of dotted horsemint to treat skin problems, and also used an infusion of dotted horsemint to reduce fevers.
The Mohegan made an infusion of the plant to reduce fevers as well. The Nanticoke similarly used an infusion of the plant.

Horsemint was used by the Winnebagos and Dakotas as a stimulant and as a treatment for cholera. Other Native Americans used the herb for a wide variety of problems, including nausea, backache, fluid retention, chills, and headache.

Bee balm contains thymol, the active compound in thyme (Thymus vulgaris), and it was a common spice among several Southwest Nations including Acoma, Apache, and Hopi. Many nations including the Omaha and Crow made perfume from the leaves.

The Blackfoot recognized the strong antiseptic action of the plants and used them in poultices for skin infections and minor wounds. Native Americans and later settlers also used it to alleviate stomach and bronchial ailments.

19th-Century Eclectic and Physiomedical Practice

Horsemint holds an important place in 19th-century American eclectic medicine. King's American Dispensatory is a 19th-century medical and botanical textbook, first published in 1854, that covers the uses of herbs used in American medical practice, especially by those involved in eclectic medicine, which was the botanical school of medicine in the 19th to 20th centuries.

The King's American Dispensatory (1898 edition) described the medicinal oil of horsemint (Oleum Monardae) in detail. Oil of horsemint is stimulant, antispasmodic, and antiemetic, and in the form of the essence has been much used to allay nausea and vomiting in Asiatic cholera, cholera morbus, etc.; it relieves the diarrhoea of debility, its action in these cases being prompt and permanent. Externally, it is rubefacient and even vesicant, and has been advantageously used in low forms of fever, cholera infantum, paralysis, rheumatic and neuralgic pains, etc.

The Physiomedical Dispensatory of 1869 (William Cook, M.D.) described the herb as follows: "This herb is diffusively stimulating and relaxant, of the distinctly carminative nervine and anti-spasmodic order. It makes a grateful and useful addition to diaphoretic drinks in the treatment of recent colds, catarrhal and typhus fevers, and measles."

Significantly, the historical recognition of horsemint as a natural source of thymol was noted in botanical literature. The American Horsemint (Monarda punctata, Linn.) is of considerable importance, as it may before long be available as a regular source of Thymol, which has hitherto been manufactured principally from Ajowan seeds. It yields from 1 to 3 per cent of a volatile oil, which contains a large proportion of Thymol, up to 61 per cent having been obtained; Carvacrol also appears to be a constituent.

Thymol was discovered by Caspar Neumann in 1719. It was purified in 1853 by M. Lallemand, who gave it the name "thymol" and ascribed the formula (old notation) C₂₀H₁₄O₂, corresponding to C₁₀H₁₄O of the new notation. The crystalline substance extracted from oil of horsemint was previously called monardin before it was confirmed to be identical to thymol. Below 5°C (39°F), the oil deposits crystals of a stearopten once called monardin, but which has subsequently been shown to be thymol (C₁₀H₁₃OH).

3. Key Constituents and Active Compounds

Essential Oil Constituents

The essential oil is the most pharmacologically studied fraction of M. punctata. Gas chromatographic mass spectrometric (GC-MS) analysis revealed the presence of 13 chemical constituents with thymol (75.2%), p-cymene (6.7%), limonene (5.4%), and carvacrol (3.5%) as the major constituents. The oil composition was dominated by the oxygenated monoterpenes. The yield of the essential oil obtained from the flowers was about 0.9% w/v, and a total of 13 components were identified constituting 97.2% of the total oil composition.

The compounds thymol, carvacrol, p-cymene, and their derivatives were the primary terpenoid components found in the essential oils of Monarda species collected in south Alabama. The known biological activities of these compounds are consistent with the traditional uses of Monarda species to treat wounds, skin infections, colds, and fevers.

The proportional composition of thymol varies by geographic origin and chemotype. The chemical composition of the oil of M. fistulosa is analogous to that of Monarda punctata, with carvacrol taking the place of its isomer thymol, contained in the latter plant. Less than 2 per cent of thymol is present in the oil of M. fistulosa.

Thymol: The Dominant Bioactive Component

Thymol (2-iso-propyl-5-methylphenol) is a naturally occurring monoterpene phenol which is isomeric with carvacrol and has shown antibacterial, antifungal, antitumor, and anti-inflammatory activities. It also acts as an antioxidant, free radical scavenger, and antilipid peroxidative agent.

Thymol and carvacrol are isomer monoterpenoid compounds with a single phenolic ring structure with three functional group substituents (hydroxyl group, methyl group and isopropyl group). Their chemical names are 2-isopropyl-5-methylphenol and 5-isopropyl-2-methylphenol, respectively. These compounds are known to be the most prevalent and powerful free radical sensors.

Non-Volatile Polyphenols and Flavonoids

Beyond the essential oil, M. punctata contains a substantial array of non-volatile phenolic compounds. HPLC-ESI-QTOF/MS/MS analysis revealed the presence of 18 different components including both phenolic acids and their derivatives (chlorogenic acid, coumarinoquinic acid, p-OH-benzoic acid, protocatechuic acid, ferulic acid, gallic acid, rosmarinic acid, p-coumaric acid, and hydroxybenzoic acid glucoside) as well as flavonoids and their derivatives (luteolin-3-glucuronide, kaempherol-3-rutinoside, luteolin-7-glucoside, apigenin-7-rutinoside, apigenin-7-glucoside, apigenin, luteolin, naringenin, and naringin) in the studied extracts. The number of ingredients in the M. punctata extract comprised 15 of those components.

A 2010 phytochemical investigation specific to M. punctata identified further constituents. An 80% acetone extract of Monarda punctata showed an inhibitory effect on lipase activity in isolated mouse plasma in vitro, and carvacrol was obtained as the active constituent. It had an IC₅₀ value of 4.07 mM in vitro and suppressed elevations in blood triacylglycerol levels in olive oil-loaded mice. Furthermore, from the whole plant, 22 compounds were isolated, including six monoterpene glycosides, a flavone glucuronide, and other known compounds identified based on spectroscopic analyses.

4. Mechanisms of Action

Antimicrobial Mechanisms

The antimicrobial mechanism of action of thymol includes (i) membrane rupture with ATP-ase activity inhibition, (ii) leakage of essential biomolecules from the cell, (iii) disruption of the proton motive force, and (iv) enzyme inactivation.

Thymol acts as a biocidal agent by causing disruption of the bacterial membrane. Numerous studies have revealed that thymol predominantly exerts its antifungal activity by disrupting the structure of the cell membrane, affecting membrane ion channels, altering the DNA structure, and interfering with the material and energy metabolism of the pathogen.

Research on the antifungal mechanism in the pathogen Cryptococcus neoformans found that thymol, a monoterpene alcohol from the Lamiaceae, exhibits antifungal activity against Cryptococcus neoformans by regulating multiple signaling pathways including calcineurin, unfolded protein response, and HOG (high-osmolarity glycerol) MAPK pathways. Thymol treatment reduced the intracellular concentration of Ca²⁺ by controlling the expression levels of calcium transporter genes in a calcineurin-dependent manner.

A comprehensive 2025 review identified the following molecular-level mechanisms of thymol's antifungal activity: cell membrane rupture, interference with cell wall synthesis, disruption of mitochondrial function and energy metabolism, inhibition of biofilm, inhibition of virulence factor expression, inhibition of key enzymes, and induction of cell apoptosis.

Anti-Inflammatory Mechanisms

Studies on closely related Monarda essential oils rich in the same constituents as M. punctata have explored anti-inflammatory pathways. Investigation in an in vitro setting using LPS-stimulated U937 cells found decreased expression of pro-inflammatory cytokine IL-6 and increased expression of miR-146a, suggestive of the involvement of the Toll-like receptor-4 signaling pathway.

Lipase Inhibition

An 80% acetone extract of Monarda punctata showed an inhibitory effect on lipase activity in isolated mouse plasma in vitro, with carvacrol identified as the active constituent, which had an IC₅₀ value of 4.07 mM in vitro and suppressed elevations in blood triacylglycerol levels in olive oil-loaded mice. This finding suggests a potential mechanism relevant to lipid metabolism, though it has not been studied in humans.

Antiemetic Mechanisms (Thymol)

A 2025 in vivo and in silico study on thymol found that molecular docking showed strong binding of thymol to 5-HT₃A (−6.4 kcal/mol), D₂ (−7.1 kcal/mol), M₃ (−6.2 kcal/mol), and H₁ (−7.1 kcal/mol) receptors, comparable to standard antiemetic drugs. This multi-receptor binding profile offers a mechanistic rationale for the traditional use of horsemint preparations in nausea and vomiting.

Pharmacokinetics of Thymol in Humans

A human pharmacokinetic study provided important data on how thymol behaves after oral administration. Each subject received a single dose of a Bronchipret TP tablet equivalent to 1.08 mg thymol. No free thymol could be detected in plasma or urine; however, the metabolites thymol sulfate and thymol glucuronide were found in urine and identified by LC-MS/MS. Thymol sulfate, but not thymol glucuronide, was detectable in plasma. Peak plasma concentrations were 93.1 ± 24.5 ng/mL and were reached after 2.0 ± 0.8 hours. The mean terminal elimination half-life was 10.2 hours. Thymol sulfate was detectable up to 41 hours after administration. The amount of both thymol sulfate and glucuronide excreted in 24-hour urine was 16.2% ± 4.5% of the dose. This study indicates that thymol undergoes rapid and extensive first-pass metabolism to sulfate and glucuronide conjugates following oral ingestion.

5. Scientific Evidence by Area of Use

Important note on evidence level: As of available literature, there are no published randomized controlled clinical trials (RCTs) in humans evaluating Monarda punctata as a whole-plant extract or supplement for any clinical endpoint. The scientific evidence available is almost entirely composed of in vitro (cell and tissue) experiments, a small number of animal studies, and one human pharmacokinetic study of thymol as an isolated constituent. Claims about the plant's effects in humans therefore remain at a traditional/historical or preclinical level.

5a. Antimicrobial Activity (Respiratory Pathogens)

Evidence type: In vitro (laboratory) only. No human clinical trials.

The aim of the key published study was to evaluate the chemical composition of the essential oil of Monarda punctata along with its antibacterial effects against some frequently encountered respiratory infection-causing pathogens. The antibacterial activity of the Monarda punctata essential oil and its major constituents (thymol, p-cymene, limonene, and carvacrol) was assessed against Streptococcus pyogenes, methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli, with effectiveness assessed by determining inhibition zones, MIC, and MBC values. Results showed that Streptococcus pyogenes, Escherichia coli, and Streptococcus pneumoniae were the most susceptible bacterial strains, showing the lowest MIC and MBC values. Methicillin-resistant Staphylococcus aureus was the most resistant bacterial strain.

The study revealed that the essential oil and its constituents exhibited a broad spectrum and variable degree of antibacterial activity against different strains. These are in vitro findings and cannot be directly extrapolated to clinical outcomes in patients with respiratory tract infections.

5b. Antifungal Activity

Evidence type: In vitro and animal models. No human clinical trials specific to horsemint or its oil.

The antifungal activity of thymol — the dominant constituent of M. punctata essential oil — has been documented across multiple in vitro studies. Thymol exhibits fungicidal activity against Candida albicans, Botrytis cinerea, Rhizopus oryzae, and Aspergillus species. Thymol, in combination with other antifungal agents such as posaconazole, fluconazole, and nystatin, can effectively reduce biofilm formation and disrupt mature biofilms, thereby enhancing the susceptibility of Candida species.

An in vitro study on oral Candida species found that the mechanism of combined thymol and nystatin appears to involve the inhibition of ergosterol formation as a result of the antifungal agents' action on the different enzymes responsible for the biosynthesis of ergosterol and/or because an increase in cell permeability allows the passage of one or both agents. This was described as the first study reporting the synergistic effect of combined thymol and nystatin and its potential use to treat superficial infections in the oral mucosa caused by Candida species. These findings are preliminary and in vitro only.

5c. Antioxidant Activity

Evidence type: In vitro. No human clinical trials.

A comparative analysis of flavonoids and phenolic acid composition in six Monarda species, including M. punctata, was conducted using methanolic extracts of flowering herbs. To differentiate the samples, the antioxidant activity of the 70% methanolic extracts was studied and expressed as EC₅₀ values; for M. punctata, the EC₅₀ was 0.150 mg/mL, placing it in the middle range among the six tested Monarda species. The antioxidant power of tested essential oils was closely related to their chemical compositions, especially carvacrol and thymol. Several studies have demonstrated that carvacrol and thymol are the main bioactive elements of the essential oils extracted from Lamiaceae species and contribute significantly to their antioxidant power. These are in vitro assay results; their relevance to in vivo antioxidant effects in humans is not established.

5d. Anti-Inflammatory Activity

Evidence type: In vitro (on closely related Monarda species). No human clinical trials.

Direct anti-inflammatory studies on M. punctata essential oil in humans are absent from the published literature. Studies on the closely related M. didyma essential oil (also rich in thymol and carvacrol) have demonstrated anti-inflammatory signals in vitro. Investigation of the anti-inflammatory effect in an in vitro setting (LPS-stimulated U937 cells) found decreased expression of pro-inflammatory cytokine IL-6 and increased expression of miR-146a, suggestive of the involvement of the Toll-like receptor-4 signaling pathway. Although further studies are needed to better investigate the action mechanisms, these findings show that the essential oil is rich in bioactive compounds which are most likely responsible for its beneficial effect.

5e. Antiemetic Activity (Thymol)

Evidence type: In vivo animal model and in silico modeling. No human clinical trials.

Thymol, a phenolic monoterpene from essential oils, was evaluated for its antiemetic potential using in vivo and in silico methods. In the in vivo study, emesis was induced in 2-day-old chicks by oral administration of copper sulfate pentahydrate (50 mg/kg). Thymol was administered orally at doses of 10, 20, and 40 mg/kg, alone or in combination with standard antiemetics including ondansetron, domperidone, hyoscine butyl bromide, and promethazine hydrochloride. The 20 mg/kg dose showed the highest efficacy, significantly (p < 0.0001) reducing the number of retches (24.6 ± 2.7; 67.2% reduction) and increasing latency to first retch (52.6 ± 4.2 s; 77.18% increase) compared to the negative control. The thymol + ondansetron combination further enhanced effects (68.53% retch reduction).

These are animal and computational data. Clinical relevance for human nausea and vomiting remains unproven.

5f. Lipid Metabolism / Lipase Inhibition

Evidence type: In vitro and animal model (mouse). No human clinical trials.

An 80% acetone extract of Monarda punctata showed an inhibitory effect on lipase activity in isolated mouse plasma in vitro, and carvacrol was obtained as the active constituent with an IC₅₀ value of 4.07 mM in vitro. It also suppressed elevations in blood triacylglycerol levels in olive oil-loaded mice. These findings are preliminary and have not been studied in humans.

6. Body Systems and Health Areas

Based on its chemical constituents and documented traditional and laboratory uses, horsemint is associated with the following body systems:

Respiratory System: Having a strong volatile oil, horsemint is primarily used for digestive and upper respiratory problems. It is taken as an infusion to relieve nausea, indigestion, flatulence, and colic. It is also employed to reduce fevers and upper respiratory mucus.
Digestive System: The leaves are carminative, diaphoretic, diuretic, emmenagogue, rubefacient, stimulant, stomachic, and vesicant. An infusion of the leaves is used in the treatment of flatulence, nausea, indigestion, catarrh in the upper respiratory tract, and to induce sweating and promote urination.
Integumentary System (Skin): The Delaware washed patients' faces with an infusion of dotted horsemint to treat skin problems. The Blackfoot used it in poultices for skin infections and minor wounds.
Musculoskeletal System: The herb is principally used externally as a rubefacient; applied as a poultice it helps to lessen the pain of arthritic joints by increasing the flow of blood in the area.
Immune / Antimicrobial: The plant contains thymol, an antiseptic and fungicide. In vitro data support activity against a range of bacterial and fungal pathogens, as detailed in Section 5.
Reproductive System (Emmenagogue): Horsemint also strongly stimulates menstruation, according to traditional herbal records. This effect has not been evaluated in clinical studies.

7. Safety Considerations and Interactions

Regulatory Status of Thymol

Thymol demonstrates low toxicity throughout its toxicity database. No adverse effects were observed at the highest dose tested (200 mg/kg/day) in thymol's toxicity database. The U.S. Environmental Protection Agency has stated that regarding the overall acute toxicological profile of thymol, the active ingredient is of minimal toxicity. Thymol is of low acute oral toxicity (Toxicity Category III), inhalation toxicity (Toxicity Category IV), and dermal toxicity (Toxicity Category III). However, it is corrosive to the skin and eye (Toxicity Category I) and may or may not be a dermal sensitizer (inconclusive).

In terms of mutagenicity, the active ingredient was determined to be non-mutagenic, and no adverse effects were identified relative to either developmental toxicity or reproductive toxicity.

Concentration-Dependent Toxicity

On acute oral administration, thymol is harmful, whereas it is practically non-toxic following acute dermal application (LD₅₀ rat oral 980 mg/kg body weight; LD₅₀ mouse oral 640–1800 mg/kg body weight; LD₅₀ rat dermal >2000 mg/kg body weight).

Concentrated thymol and the neat essential oil represent higher-risk preparations. Ingesting concentrated thymol can lead to severe chemical burns in the mouth and GI tract, along with systemic toxicity, including seizures and cardiac issues. Long-term occupational exposure to high concentrations of thymol dust has been linked to changes in lung function.

Genotoxicity Data

The genotoxicity data on thymol are mixed. Oral administration of thymol does not induce micronuclei in mice even in the toxic dose range. In the Salmonella/microsome assay, thymol exhibits no mutagenic effect. However, it has been reported to give positive results in the Unscheduled DNA Synthesis test and in the Sister Chromatid Exchanges test with embryonic cells of the Syrian hamster. The findings are statistically significant, though there is no strict dose-response relationship.

Skin and Eye Corrosivity

Individuals with sensitivities or allergies to plants in the Lamiaceae family (which includes thyme) may experience allergic reactions. The essential oil has rubefacient and vesicant properties when applied to skin at full strength, as has been consistently noted across both historical and modern sources. Carvacrol, the isomer of thymol also present in horsemint oil, applied full strength to intact or abraded rabbit skin for 24 hours under occlusion was severely irritating.

Emmenagogue Warning

Horsemint strongly stimulates menstruation according to traditional herbal records. This emmenagogue property, described in multiple historical sources, implies the plant has historically been considered inappropriate for use during pregnancy. No modern clinical data are available to quantify this risk.

Known Species Confusion

The title "bee balm" refers to bees' appreciation of a plant rather than the plant itself; for this reason, many different species are known commonly as "bee balm," including Monarda didyma, M. fistulosa, and a number not botanically related to horsemint at all. To distinguish this species from others, the common name "horsemint" or the scientific name Monarda punctata is used. This nomenclatural overlap makes it important to verify species identity when interpreting both historical records and product labeling.

8. Overall Evidence Assessment

As confirmed by a 2021 literature review, only 49 original studies and reviews were retrievable from PubMed up to November 2020 about the chemical composition and biological activities of species from the Monarda genus. Scientifically confirmed pharmacological activities of Monarda plants were primarily revealed by researchers due to the composition of essential oils isolated from the aerial parts of M. fistulosa, M. didyma, M. citriodora, and M. punctata.

The other groups of biologically active compounds of Monarda genus representatives such as flavonoids or hydroxycinnamic acids were studied less.

The body of evidence for horsemint (Monarda punctata) as of the available literature is characterized by:

Strong traditional record across multiple Native American traditions and 19th-century North American botanical medicine for respiratory, digestive, and cutaneous applications.
Well-characterized phytochemistry, with thymol as the dominant and most pharmacologically studied constituent.
Preclinical evidence (in vitro and animal models) supporting antimicrobial, antifungal, antioxidant, anti-inflammatory, antiemetic, and lipase-inhibitory activities, largely attributable to thymol and carvacrol.
No published human randomized controlled trials evaluating the whole plant, its extract, or its essential oil for any clinical health outcome.
One human pharmacokinetic study establishing metabolic handling of thymol after oral dosing, but at a dose (1.08 mg) from a pharmaceutical combination product.

References

Health Conditions

Health conditions that Horsemint may help support.

No conditions available.

Body Systems

Body systems that Horsemint may help support.

No body systems available.